CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 500 filers reported holding CRISPR THERAPEUTICS AG in Q2 2021. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $231,000 | -32.3% | 3,050 | 0.0% | 0.15% | -16.4% |
| Q3 2021 | $341,000 | -31.0% | 3,050 | 0.0% | 0.18% | -38.0% |
| Q2 2021 | $494,000 | +32.8% | 3,050 | 0.0% | 0.30% | +8.5% |
| Q1 2021 | $372,000 | -20.3% | 3,050 | 0.0% | 0.27% | -41.5% |
| Q4 2020 | $467,000 | +46.9% | 3,050 | -19.7% | 0.46% | +31.0% |
| Q3 2020 | $318,000 | +14.0% | 3,800 | 0.0% | 0.36% | -30.9% |
| Q2 2020 | $279,000 | +20.8% | 3,800 | 0.0% | 0.51% | -26.4% |
| Q4 2019 | $231,000 | -45.4% | 3,800 | -47.2% | 0.70% | +120.9% |
| Q2 2018 | $423,000 | +14.3% | 7,200 | -11.1% | 0.32% | +12.1% |
| Q1 2018 | $370,000 | +94.7% | 8,100 | 0.0% | 0.28% | +107.4% |
| Q4 2017 | $190,000 | – | 8,100 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $31,294,000 | 31.24% |
| NEA Management Company, LLC | 1,590,002 | $365,593,000 | 10.56% |
| Ariose Capital Management Ltd | 37,900 | $2,379,000 | 9.30% |
| ARK Investment Management | 9,404,071 | $590,294,000 | 2.46% |
| NIA IMPACT ADVISORS, LLC | 80,082 | $5,027,000 | 2.44% |
| Nikko Asset Management Americas, Inc. | 4,619,747 | $291,044,000 | 2.14% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,139,000 | 1.98% |
| Integral Health Asset Management, LLC | 120,000 | $7,532,000 | 1.96% |
| Valiant Capital Management, L.P. | 240,683 | $15,108,000 | 1.73% |
| Deuterium Capital Management, LLC | 18,000 | $1,130,000 | 1.45% |